Published in Circulation on July 01, 1976
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Streptococcal anti-desoxyribonuclease B: microtechnique determination. J Lab Clin Med (1968) 3.88
Simulation technology for health care professional skills training and assessment. JAMA (1999) 3.49
The influence of the site of infection on the immune response to group A streptococci. J Clin Invest (1970) 3.07
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol (1986) 2.36
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol (2000) 2.14
Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis (1989) 2.09
Experimental IgA nephropathy. J Exp Med (1979) 2.09
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med (1968) 1.95
Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis (1977) 1.94
Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication? Am J Med Genet (1996) 1.83
Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol (1983) 1.76
Abandoning empirical antibiotics for febrile children. Lancet (1997) 1.75
Multimedia computer-assisted instruction in cardiology. Arch Intern Med (1995) 1.72
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet (2000) 1.68
Kawasaki disease in infants less than one year of age. J Pediatr (1995) 1.67
Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation (1982) 1.64
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr (1997) 1.64
CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis (2001) 1.62
Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics (1999) 1.61
Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA (1997) 1.61
Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci (2001) 1.60
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr (1991) 1.60
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis (2000) 1.58
Clinical aspects of acute rheumatic fever. J Rheumatol Suppl (1991) 1.57
Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol (1972) 1.55
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health (2003) 1.55
Kawasaki syndrome. Rev Infect Dis (1988) 1.55
Kawasaki syndrome. Pediatr Clin North Am (1999) 1.53
Axial cineangiography in congenital heart disease. Section I. Concept, technical and anatomic considerations. Circulation (1977) 1.52
New presumptive identification test for Clostridium perfringens: reverse CAMP test. J Clin Microbiol (1980) 1.52
Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr (1988) 1.49
A comparison of ampicillin and chloramphenicol therapy in Hemophilus influenzae meningitis. Pediatrics (1971) 1.48
Evaluation of an ELISA for group A streptococcal antigen for diagnosis of pharyngitis. J Pediatr (1987) 1.47
Incomplete Kawasaki disease with coronary artery involvement. J Pediatr (1987) 1.46
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol (1997) 1.44
The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J Virol (1992) 1.41
Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics (1985) 1.38
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Pathogenetic mechanisms in congenital cardiovascular malformations. Prog Cardiovasc Dis (1972) 1.35
Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics (1983) 1.33
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
Percutaneous balloon valvuloplasty for pulmonic valve stenosis in the adult. Am J Cardiol (1982) 1.32
Fluorescence in situ hybridization analysis of keratinocyte growth factor gene amplification and dispersion in evolution of great apes and humans. Proc Natl Acad Sci U S A (1997) 1.29
Kawasaki syndrome. Clin Microbiol Rev (1998) 1.28
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Sleep apnea as a possible cause of pulmonary hypertension in Down syndrome. J Pediatr (1981) 1.27
Does Kawasaki disease have a retroviral aetiology? Lancet (1986) 1.26
Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J (1987) 1.26
Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir. J Clin Microbiol (1987) 1.25
Cardiovascular manifestations in the Larsen syndrome. Pediatrics (1983) 1.24
Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem (1995) 1.24
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23
Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics (1994) 1.23
The fate of group A streptococci following phagocytosis. In vitro phagocytic studies of isotope-labeled streptococci. J Immunol (1967) 1.21
Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis (1987) 1.21
Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr (1985) 1.21
Neurocysticercosis among children in Chicago. Clin Infect Dis (1996) 1.21
High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry (1989) 1.21
Intraphagocytic degradation of group A streptococci: electron microsopic studies. J Bacteriol (1969) 1.20
Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J (1987) 1.19
Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control (2001) 1.18
Use of bisulfite in the streptococcal anti-nicotinamide adenine dinucleotidase test. Appl Microbiol (1966) 1.17
Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol (2001) 1.16
Intraphagocytic beta-N-acetylglucosaminidase. Properties of the enzyme and its activity on group A streptococcal carbohydrate in comparison with a soil bacillus enzyme. J Exp Med (1968) 1.16
IgG and IgM pneumococcal polysaccharide antibody responses in infants. Pediatr Res (1984) 1.16
Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. J Infect Dis (1981) 1.16
Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J Immunol (1988) 1.15
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Kawasaki disease in older children and adolescents. J Pediatr (2000) 1.15
Successful treatment of systemic Chromobacterium violaceum infection. JAMA (1974) 1.15
Erythromycin prophylaxis for pertussis. Pediatrics (1977) 1.14
Transient tricuspid insufficiency of the newborn: a form of myocardial dysfunction in stressed newborns. Pediatrics (1977) 1.13
Cardiac transplantation for Kawasaki disease. Pediatrics (1997) 1.13
Periorbital and orbital cellulitis in children. Pediatrics (1978) 1.13
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. J Infect Dis (1986) 1.12
Anaphylactoid purpura: streptococcal antibody titers and beta1c-globulin levels. J Pediatr (1969) 1.11
Right aortic arch associated with contralateral congenital subclavian steal syndrome. Am J Roentgenol Radium Ther Nucl Med (1970) 1.10
Postoperative assessment of shoulder function: a prospective study of full-thickness rotator cuff tears. J Shoulder Elbow Surg (1997) 1.10
Cellular immune responses to extracellular streptococcal products in rheumatic heart disease. J Clin Invest (1981) 1.10
Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis (1973) 1.10
Factors influencing adherence of group B streptococci to human vaginal epithelial cells. Infect Immun (1979) 1.10
Properties of extracellular neuraminidase produced by group A streptococcus. Infect Immun (1979) 1.09